U.S. drug regulator flags data integrity, maintenance lapses at Dabur India plant

The findings, ‌issued ⁠after the FDA inspected the company’s factory in ⁠Dadra and Nagar Haveli in January, said some units in the facility posed risks of microbiological contamination